AstraZeneca racks up $275 million with vaccine sales
AstraZeneca’s first-quarter earnings doubled, with its Covid-19 vaccine generating $275 million in revenue. The pharma company’s revenue for the quarter rose 15 percent
Denmark Austria temporarily suspend AstraZeneca vaccine over blood clot reports
Denmark has decided to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford due to reports of adverse blood clot reactions a
Oxford/AstraZeneca Covid vaccine to be approved by the UK within days
CEO of AstraZeneca, Pascal Soriot, recently stated that researchers are vehemently working to fish out the ‘winning formula’ to boost the Oxford COVID-19 vaccine. The C
AstraZenaca to Buy Rare Disease Specialist Alexion for $39 billion
Get upcoming M&A news and updates here at the nation’s fastest-growing CEO magazine, Industry Leaders.
AstraZeneca to Begin Supplying COVID-19 Vaccine in September
The University of Oxford and AstraZeneca Plc have begun recruiting over 10,000 subjects for advanced human trials of experimental COVID-19 vaccine. If everything goes as planned, t
Brexit shows no signs of mercy to drugmakers
Britain’s departure from the EU has forced companies including AstraZeneca Plc, GlaxoSmithKline Plc and Merck & Co. to build stockpiles of their medicines in preparation for
Pfizer CEO Ian Read eager to court his company with ‘Botox Maker’ Allergan!
Pharmaceutical behemoth Pfizer has reportedly been in talks for acquisition of Allergan, which could be touted as the biggest acquisition of the year. This acquisition will create
Drug Giant AstraZeneca to Slash 1,600 jobs
AstraZeneca PLC, the global pharmaceutical giant and the UK’s second biggest drug company, informed that it planned to restructure itself by introducing downsizing program and re
